TRIAZINE COMPOUND AND COMPOSITION AND USE THEREOF

The present invention relates to the field of medicine, and specifically relates to a triazine compounds as represented by formula (I), or a stereoisomer, a tautomer, a nitrogen oxide, a solvate, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the compound, and...

Full description

Saved in:
Bibliographic Details
Main Authors WANG, Tingjin, XI, Ning, XU, Shimin
Format Patent
LanguageEnglish
Published 07.09.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to the field of medicine, and specifically relates to a triazine compounds as represented by formula (I), or a stereoisomer, a tautomer, a nitrogen oxide, a solvate, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the compound, and use of the compound and the pharmaceutical composition thereof in the preparation of drugs for treating and/or preventing proliferative disease, autoimmune diseases, allergic diseases, inflammatory diseases, transplant rejection, cancers, viral infectious diseases, or other diseases in mammals. The compound provided by the present invention exhibits excellent inhibitory activity and kinase selectivity against a target kinase.
AbstractList The present invention relates to the field of medicine, and specifically relates to a triazine compounds as represented by formula (I), or a stereoisomer, a tautomer, a nitrogen oxide, a solvate, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the compound, and use of the compound and the pharmaceutical composition thereof in the preparation of drugs for treating and/or preventing proliferative disease, autoimmune diseases, allergic diseases, inflammatory diseases, transplant rejection, cancers, viral infectious diseases, or other diseases in mammals. The compound provided by the present invention exhibits excellent inhibitory activity and kinase selectivity against a target kinase.
Author XI, Ning
WANG, Tingjin
XU, Shimin
Author_xml – fullname: WANG, Tingjin
– fullname: XI, Ning
– fullname: XU, Shimin
BookMark eNrjYmDJy89L5WQwDAnydIzy9HNVcPb3DfAP9XNRcARiMCfYM8TT3w_MDw12VQjxcA1y9XfjYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkbGRuaWBkYmjobGxKkCAPbiKUc
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2023279024A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2023279024A13
IEDL.DBID EVB
IngestDate Fri Oct 04 05:02:01 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2023279024A13
Notes Application Number: US202118015381
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230907&DB=EPODOC&CC=US&NR=2023279024A1
ParticipantIDs epo_espacenet_US2023279024A1
PublicationCentury 2000
PublicationDate 20230907
PublicationDateYYYYMMDD 2023-09-07
PublicationDate_xml – month: 09
  year: 2023
  text: 20230907
  day: 07
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies BEIJING FINDCURE BIOSCIENCES, LTD
RelatedCompanies_xml – name: BEIJING FINDCURE BIOSCIENCES, LTD
Score 3.4853184
Snippet The present invention relates to the field of medicine, and specifically relates to a triazine compounds as represented by formula (I), or a stereoisomer, a...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title TRIAZINE COMPOUND AND COMPOSITION AND USE THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230907&DB=EPODOC&locale=&CC=US&NR=2023279024A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKeqbTsXLlILSt2Kvtj4U6dqUVuiFXmT4MpothYF0w1X8-56GTve0h0BODuQGJ9_5kpwE4FGhTKkUg0rzmsqSrmsLicpMkyyLLWSl7hCsCxSO4ueg1N-mxnQAn9tYGP5O6A9_HBEtao723vL1ev2_ieXxu5WbJ7rEotWrX9ie2LNj9KeR7InexCZp4iWu6Lp2mYtxxnWq-YKI5CBXOkBH2uzsgbxPuriU9S6o-KdwmGJ9TXsGA9aM4Njd_r02gqOoP_LGbG99m3NQiix0PsKYCG4SpUkZe4KDiQt52O01cbnMiVAEJCOJfwEPPincQMK2Z39DnZX5bke1Sxg2q4ZdgWCqFVURTWSqWXpVWRXTarlSmIHs1tBrdg3jfTXd7Fffwkkn8rtT5hiG7dc3u0Owbek9n6Nfjct9eQ
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQWlb8VmbW19KNK1Ka2u7VhbGb6MZktBkG64iv--17DpnvYQSHKQL7j88rvcJQD3hHFSEIMps5Kpiq5rc4WpXFMsi89VUjYI1gQKR_FjkOsvE2PSgs9NLIx4J_RHPI6IGjVDfa_Ffr38N2J5wrdy9cA-sGrx7Ge2J6_ZMZ6nkezJ3sCmo8RLXNl17TyV47GQ9c0nRCQHudIeHrKt5r8D-jZo4lKW26DiH8H-CNur6mNo8aoLHXfz91oXDqL1lTdm19q3OgGSjUPnPYyp5CbRKMljT3IwiUIaNrYmUc5TKmUBHdPEP4U7n2ZuoGDf07-pTvN0e6DaGbSrRcXPQTL7BesjmqhMs_SisAqulWpBuIHs1tBLfgG9XS1d7hbfQifIouF0GMavV3DYiIQfldmDdv31za8ReGt2I9brF5ergGk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TRIAZINE+COMPOUND+AND+COMPOSITION+AND+USE+THEREOF&rft.inventor=WANG%2C+Tingjin&rft.inventor=XI%2C+Ning&rft.inventor=XU%2C+Shimin&rft.date=2023-09-07&rft.externalDBID=A1&rft.externalDocID=US2023279024A1